Yesterday I attended the Jessie Mole Memorial Lecture in Oxford with Don Grocott, RPFB’s Chairman and RPFB trustees Roger Backhouse and Lucy Withington. This year’s lecture was delivered by Prof Chris Inglehearn, who has worked with the charity for many years. The lecture was incorporated into the Oxford Ophthalmology Updates Day, a sight loss professionals event held annually.
Jessie Mole was a very important figure in the early days of the organisation. In April 1975 she wrote the Deed of Trust for the charity, then the British Retinitis Pigmentosa Society, which was founded by her niece Lynda Cantor. She worked tirelessly for the charity, serving as Treasurer, Chairman of the Management Committee and then Chairman of the Board of Trustees. Jessie died on 24 March 2000 and The Jessie Mole Lecture was inaugurated on 10 December 2001, in recognition of her outstanding contribution to the charity.
Prof Inglehearn’s lecture was entitled ‘Retinal Diseases and the prospect for therapy in the genome era’. It covered some of the biggest advances in genomics and paid tribute to those who have done so much to further our cause and build scientific understanding of inherited retinal dystrophies.
As is tradition, Prof Inglehearn was presented with a commemorative medal to make the occasion. Huge thanks must go to Prof Susan Downes who organised the day, and of course to Prof Inglehearn for consenting to deliver this important lecture.
Communications & PR Manager